X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

PATHOLOGY

期刊標題檢索 PATHOLOGY 最新評論: Is it a direct rejection or is there a process of being Under Review?... (2022-06-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[PATHOLOGY]您好,您是該頁面的第 29615 位訪客。

期刊簡介
期刊名稱PATHOLOGY PATHOLOGY
LetPub Score
6.3
50 ratings
Rate

Reputation
7.6

Influence
5.1

Speed
7.0

期刊簡稱PATHOLOGY
ISSN0031-3025
E-ISSN1465-3931
h-index57
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.500.9191.090
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q136 / 208

自引率 (2023-2024)2.80%自引率趨勢
掲載範囲
Published by Elsevier from 2016

Pathology is the official journal of the Royal College of Pathologists of Australasia (RCPA). It is committed to publishing peer-reviewed, original articles related to the science of pathology in its broadest sense, including anatomical pathology, chemical pathology and biochemistry, cytopathology, experimental pathology, forensic pathology and morbid anatomy, genetics, haematology, immunology and immunopathology, microbiology and molecular pathology.
官方網站http://journals.lww.com/pathologyrcpa/Pages/default.aspx
在線稿件提交https://www.editorialmanager.com/PAT
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區AUSTRALIA
發行頻率四半期刊行
創刊年1969
每年文章數91每年文章數趨勢
黃金OA百分比16.73%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PATHOLOGYSCIEQ120/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-3025%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【PATHOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports314297
    DISEASE MARKERS92610
    PATHOLOGY RESEARCH AND PRACTICE68295
    LABORATORY INVESTIGATION67483
    JOURNAL OF PATHOLOGY65723
    AMERICAN JOURNAL OF PATHOLOGY61175
    ACTA NEUROPATHOLOGICA44158
    Diagnostic Pathology43859
    PATHOLOGY & ONCOLOGY RESEARCH43748
    MODERN PATHOLOGY41699
  •  

    PATHOLOGY PATHOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [PATHOLOGY] 的評論撰寫評論
作者: 四风丹山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-13 19:32:04 評論於
Is it a direct rejection or is there a process of being Under Review?
(0) 讚! | 四风丹山

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-12 16:35:39 評論於
Review speed: 1.0 | Submission hit rate: 25.0
Emphasized research direction: Experience sharing on renal ischemia-reperfusion
Submitted on 2022.05.21, rejected on 2022.06.11, response content: I regret to inform you that, after having been assessed by a member of the Editorial Board, it has been recommended that your manuscript be returned to you
(0) 讚! | 宗室芳蔼

作者: 宗室芳蔼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-11 17:38:22 評論於
Review speed: 1.0 | Submission success rate: 25.0 
Emphasized research direction: Experience sharing on renal ischemia-reperfusion
Date of submission: May 21, 2022
Date of rejection: June 12, 2022
Response: I regret to inform you that, after having been assessed by a member of the Editorial Board, it has been recommended that your manuscript be returned to you
(0) 讚! | 宗室芳蔼

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:01:09 評論於
Research subject/experimental conditions/some kind of experimental treatment/experimental conclusions and other elements
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:54:32 評論於
The title of the paper should be concise, not too long. The shorter the better, avoiding unnecessary words as much as possible while accurately reflecting and clearly expressing the most important specific content. Shorter paper titles generally have higher citation rates
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 19:53:06 評論於
What to Do When the Article Title is Too Long?
(0) 讚! | 北国博达

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 09:31:44 評論於
What key points should be included in an article title?
(0) 讚! | 八坂篷蔚

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [PATHOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*